Thanks PB, if only all MD's took the time to reply to Share...

Thanks PB, if only all MD's took the time to reply to Share Holders. We all should realize that Stirling has a significant number of income streams about to crank up, I do get they need funds to facilitate this.

Hi Aptayl,


Great to see your support as well as your questioning that I do regard as responsible and quite reasonable.


As is detailed in our Explanatory Memorandum and releases to the market, we do have funding requirements, especially with three of our integrated business units heading to growing cashflow. The good and bad of this is that the growth in sales of course is going to be most welcome and the flip side is that we are going to have to fund this growth. As disclosed this means funding production, cost of raw materials, packaging and manufacturing overheads etc. Then comes freight, inventory and receivables once sold. The bigger our growth (the good) the more we will need to fund this (the bad). This is especially the case when we have a market cap of only 11 odd million which is the reason why we have the provision for the additional 400m shares - hopefully we will not need to utilise this but never the less if we do not make provision we may have issues with funding growth, we just need to see how it all pans out as we grow up - market cap, sales growth, potential relationships with our drug delivery platform etc - all can influence. As you will note there is no MD Report included in the AGM notice and suggest that this will include an update of where we are positioned when released prior to our meeting.


Regards,


Peter